
The Indian Council of Medical Research (ICMR) in its guidelines for the vaccination drive said the recipients of ‘Covaxin’ COVID-19 vaccine will remain at the vaccination site for at least 30 minutes under observation to record any adverse event. The recipients will be followed-up for a period of three months after the second dose of vaccination, it added.
A Standard Operating Procedure (SoP) has been issued by ICMR for the restricted use authorisation of Covaxin under clinical trial mode. In case of severe/serious adverse event at any given point of time after vaccination, the recipient will report to the nearest health facility for treatment and will also inform the designated vaccinator.
“He/she will return to the session site on day 28 or on the date given to him/her for the 2nd dose of Covaxin. All the vaccine recipients will be followed-up for a period of 3 months after the second dose of vaccination,” the SoPs stated.
The individuals with the following conditions will not be eligible for vaccination — have any history of allergies, have a fever, bleeding disorder or are on a blood thinner, are immunocompromised, or are on a medicine that affects their immune system, pregnant, breastfeeding, have received another COVID-19 vaccine, any other serious health-related issues as determined by the Vaccinator/Officer supervising vaccination.